Connect with others who understand.

sign up log in
About mySMAteam

Connect with others who understand.

sign up log in
About mySMAteam
SMA
NEWS

Study Looks at Economic Burden of Spinal Muscular Atrophy

Posted on September 16, 2021
Medically reviewed by
Evelyn O. Berman, M.D.
Article written by
Maureen McNulty

  • Researchers conducted a study analyzing the financial impact of spinal muscular atrophy (SMA).
  • The study authors combined data from 15 studies that analyzed how much money is typically spent on SMA treatments and other costs.
  • The cost of health care and specific SMA drug treatments can be very high, and some treatments may not be cost-effective.

Cost often plays a role when it comes to deciding on medical treatments. Getting a clearer picture of the financial impact of SMA can help families plan ahead. It can also help doctors better understand what families are going through. Finally, pharmaceutical companies and insurance companies use economic studies to help determine how much to charge and reimburse for medications.

A study published on Jan. 23 in Orphanet Journal of Rare Diseases sheds light on the economic burden that often comes with SMA. The authors found nine previously published studies that analyzed the cost of SMA care, and six additional studies that looked at whether SMA treatments were cost-effective.

When analyzing expenses related to SMA, studies looked at health care costs in addition to other types of spending. Some studies analyzed nonmedical costs, such as making the home more accessible, while others also collected data about indirect expenses. These indirect costs included things like loss of income when a parent had to miss work to provide care.

The authors found that expenses varied based on the type of SMA. Costs for treating the most common type of SMA, called SMA type 1 or Werdnig-Hoffmann disease, ranged from $75,047 to $196,429 per year. Expenses for SMA type 2, SMA type 3, and SMA type 4 fell between $27,157 and $82,474 per year.

Drugs for SMA can be extremely expensive. For example, Zolgensma (onasemnogene abeparvovec-xioi) costs $2.1 million for a one-time injection in the United States. However, some research suggests that other health care costs may decrease when these drugs are used.

This study also aimed to analyze whether SMA treatments were cost-effective. The authors compared the cost of a drug to the health outcomes that the drug could provide. Although there are medications that can reduce symptoms and improve quality of life for people with SMA, the authors concluded that these treatments could not be considered cost-effective because they were so expensive. However, they also noted that cost was not the only important factor. These treatments have other benefits, such as improving symptoms, reducing hospital admissions, and lessening the burden on caregivers and family.

The researchers speculated that as companies develop additional SMA drugs, prices may become lower over time. “With the arrival on the market of three therapies, prices should tend to decrease, which could then make the prices more acceptable,” the authors wrote.

All updates must be accompanied by text or a picture.
Evelyn O. Berman, M.D. is a neurology and pediatric specialist and treats disorders of the brain in children. Review provided by VeriMed Healthcare Network. Learn more about her here.
Maureen McNulty studied molecular genetics and English at Ohio State University. Learn more about her here.

Related articles

The SMA community officially recognizes August as Spinal Muscular Atrophy Awareness Month. In...

UCSF Health and mySMAteam Partnership: SMA Awareness Month 2022

The SMA community officially recognizes August as Spinal Muscular Atrophy Awareness Month. In...
Medical treatments have dramatically changed the prognosis (outlook) for people living with...

Spinal Muscular Atrophy Life Expectancy: What’s Known and What’s Unknown?

Medical treatments have dramatically changed the prognosis (outlook) for people living with...
Spinal muscular atrophy (SMA) is a rare genetic condition that causes a decline in muscle...

Living With Adult Onset SMA: Diagnosis, Treatment, and Outlook

Spinal muscular atrophy (SMA) is a rare genetic condition that causes a decline in muscle...
Spinal muscular atrophy (SMA) presents daily challenges to those living with the condition. The...

Assistive Equipment for Spinal Muscular Atrophy

Spinal muscular atrophy (SMA) presents daily challenges to those living with the condition. The...
What you eat can have a tremendous impact on your health. Proper diet and nutrition are not only...

Fatty Acids, Nutrition, and SMA: Can Changes in Diet Help?

What you eat can have a tremendous impact on your health. Proper diet and nutrition are not only...
Many teenagers and adults who have been diagnosed with spinal muscular atrophy (SMA) find it...

Adaptive Equipment for Driving With SMA

Many teenagers and adults who have been diagnosed with spinal muscular atrophy (SMA) find it...

Recent articles

About one-third of people with spinal muscular atrophy (SMA) are adults.Adults with SMA may have...

Treatment Options for Adults with SMA

About one-third of people with spinal muscular atrophy (SMA) are adults.Adults with SMA may have...
Clinical trials may test new drugs or new dosages or combinations of drugs for spinal muscular...

5 Reasons To Consider Participating in SMA Clinical Trials

Clinical trials may test new drugs or new dosages or combinations of drugs for spinal muscular...
Clinical trials for spinal muscular atrophy (SMA) test new treatments, new dosages of existing...

How Do Clinical Trials Work for SMA?

Clinical trials for spinal muscular atrophy (SMA) test new treatments, new dosages of existing...
Clinical trials are designed with safety as a primary concern.Before a new drug, new dosage, or...

Are Clinical Trials Safe for People With SMA?

Clinical trials are designed with safety as a primary concern.Before a new drug, new dosage, or...
Costs for spinal muscular atrophy (SMA) medications are high, but financial assistance programs...

Tips for Staying on Spinal Muscular Atrophy (SMA) Therapies

Costs for spinal muscular atrophy (SMA) medications are high, but financial assistance programs...
The Centers for Disease Control and Prevention (CDC) has approved a second COVID-19 booster shot...

What People With SMA Should Know About Getting a Second COVID-19 Booster Shot

The Centers for Disease Control and Prevention (CDC) has approved a second COVID-19 booster shot...
SMA News
SMA News

Thank you for subscribing!

Become a member to get even more:

sign up for free

close